122 related articles for article (PubMed ID: 32389051)
21. HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.
Montironi R; Mazzucchelli R; Barbisan F; Stramazzotti D; Santinelli A; Scarpelli M; Lòpez Beltran A
Hum Pathol; 2006 Sep; 37(9):1137-44. PubMed ID: 16938518
[TBL] [Abstract][Full Text] [Related]
22. Prostate cancer grading: the effect of stratification of needle biopsy Gleason Score 4 + 3 as high or intermediate grade.
Fanning DM; Kay E; Fan Y; Fitzpatrick JM; Watson RW
BJU Int; 2010 Mar; 105(5):631-5. PubMed ID: 19732053
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of Gleason score 3 + 4 = 7 prostate cancer with minimal amounts (<6%) vs ≥6% of Gleason pattern 4 tissue in needle biopsy specimens.
Kır G; Seneldir H; Gumus E
Ann Diagn Pathol; 2016 Feb; 20():48-51. PubMed ID: 26750655
[TBL] [Abstract][Full Text] [Related]
24. Preimplantation factor negates embryo toxicity and promotes embryo development in culture.
Stamatkin CW; Roussev RG; Stout M; Coulam CB; Triche E; Godke RA; Barnea ER
Reprod Biomed Online; 2011 Oct; 23(4):517-24. PubMed ID: 21900046
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical expression of Ets-related gene-transcriptional factor in adenocarcinoma prostate and its correlation with Gleason score.
Mannan R; Bhasin TS; Manjari M; Singh G; Bhatia PK; Sharma S
Indian J Pathol Microbiol; 2016; 59(4):489-495. PubMed ID: 27721279
[TBL] [Abstract][Full Text] [Related]
26. Percentage of Gleason pattern 4 and tumor volume predict adverse pathological stage and margin status at radical prostatectomy in grade Group 2 and grade Group 3 prostate cancers.
Iakymenko OA; Lugo I; Briski LM; Nemov I; Punnen S; Kwon D; Pollack A; Stoyanova R; Parekh DJ; Jorda M; Gonzalgo ML; Kryvenko ON
Prostate; 2021 Sep; 81(12):866-873. PubMed ID: 34184782
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical detection of tyrosine phosphatase SHP-1 predicts outcome after radical prostatectomy for localized prostate cancer.
Tassidis H; Brokken LJ; Jirström K; Ehrnström R; Pontén F; Ulmert D; Bjartell A; Härkönen P; Wingren AG
Int J Cancer; 2010 May; 126(10):2296-307. PubMed ID: 19795453
[TBL] [Abstract][Full Text] [Related]
28. Preimplantation factor (PIF) promotes human trophoblast invasion.
Moindjie H; Santos ED; Loeuillet L; Gronier H; de Mazancourt P; Barnea ER; Vialard F; Dieudonne MN
Biol Reprod; 2014 Nov; 91(5):118. PubMed ID: 25232018
[TBL] [Abstract][Full Text] [Related]
29. Role of prostate health index to predict Gleason score upgrading and high-risk prostate cancer in radical prostatectomy specimens.
Kim H; Jung G; Kim JH; Byun SS; Hong SK
Sci Rep; 2021 Aug; 11(1):17447. PubMed ID: 34465825
[TBL] [Abstract][Full Text] [Related]
30. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
Jack GS; Cookson MS; Coffey CS; Vader V; Roberts RL; Chang SS; Smith JA; Shappell SB
J Urol; 2002 Aug; 168(2):519-24. PubMed ID: 12131301
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy.
Hollemans E; Verhoef EI; Bangma CH; Rietbergen J; Roobol MJ; Helleman J; van Leenders GJLH
Histopathology; 2020 Apr; 76(5):755-762. PubMed ID: 31944367
[TBL] [Abstract][Full Text] [Related]
32. Significance of nuclear factor - kappa beta activation on prostate needle biopsy samples in the evaluation of Gleason score 6 prostatic carcinoma indolence.
Zupancic M; Pospihalj B; Cerovic S; Gazic B; Drev P; Hocevar M; Perhavec A
Radiol Oncol; 2020 Apr; 54(2):194-200. PubMed ID: 32324163
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of the presence of tertiary Gleason grade 5 in robot-assisted radical prostatectomy specimens in Japanese patients with clinically localized prostate cancer.
Kamoda N; Ohori M; Hirasawa Y; Inoue R; Hashimoto T; Satake N; Gondo T; Nakagami Y; Nagao T; Ohno Y
Jpn J Clin Oncol; 2019 Mar; 49(3):276-280. PubMed ID: 30649377
[TBL] [Abstract][Full Text] [Related]
34. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
[TBL] [Abstract][Full Text] [Related]
35. Correlation between
Navaei AH; Walter BA; Moreno V; Pack SD; Pinto P; Merino MJ
J Cancer; 2017; 8(13):2604-2613. PubMed ID: 28900498
[No Abstract] [Full Text] [Related]
36. Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.
Özsoy M; D'Andrea D; Moschini M; Foerster B; Abufaraj M; Mathieu R; Briganti A; Karakiewicz PI; Roupret M; Seitz C; Czech AK; Susani M; Shariat SF
Urol Oncol; 2018 Apr; 36(4):158.e1-158.e6. PubMed ID: 29288003
[TBL] [Abstract][Full Text] [Related]
37. Correlation of Preoperative and Radical Prostatectomy Gleason Score: Examining the Predictors of Upgrade and Downgrade Results.
Pourmand G; Gooran S; Hossieni SR; Guitynavard F; Safavi M; Sharifi A; Mokhtari E
Acta Med Iran; 2017 Apr; 55(4):249-253. PubMed ID: 28532136
[TBL] [Abstract][Full Text] [Related]
38. The influence of the presence of intraductal carcinoma of the prostate on the grade group system's prognostic performance.
Kato M; Hirakawa A; Kobayashi Y; Yamamoto A; Ishida R; Sano T; Kimura T; Majima T; Ishida S; Funahashi Y; Sassa N; Fujita T; Matsukawa Y; Yamamoto T; Hattori R; Gotoh M; Tsuzuki T
Prostate; 2019 Jul; 79(10):1065-1070. PubMed ID: 31025722
[TBL] [Abstract][Full Text] [Related]
39. Comparative influence of cribriform growth and percent Gleason 4 in prostatic biopsies with Gleason 3+4 cancer.
Czaja RC; Tarima S; Wu R; Palagnmonthip W; Iczkowski KA
Ann Diagn Pathol; 2021 Jun; 52():151725. PubMed ID: 33610958
[TBL] [Abstract][Full Text] [Related]
40. Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer.
Kim J; Davis JW; Klein EA; Magi-Galluzzi C; Lotan Y; Ward JF; Pisters LL; Basler JW; Pettaway CA; Stephenson A; Li Ning Tapia EM; Efstathiou E; Wang X; Do KA; Lee JJ; Gorlov IP; Vornik LA; Hoque AM; Prokhorova IN; Parnes HL; Lippman SM; Thompson IM; Brown PH; Logothetis CJ; Troncoso P
EBioMedicine; 2016 May; 7():85-93. PubMed ID: 27322462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
